CAPTRUST Financial Advisors’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,219
| Closed | -$210K | – | 2509 |
|
|
2023
Q4 | $210K | Buy |
+6,219
| New | +$210K | ﹤0.01% | 2367 |
|
|
2022
Q4 | – | Sell |
-4,185
| Closed | -$223K | – | 2153 |
|
|
2022
Q3 | $223K | Sell |
4,185
-5,537
| -57% | -$295K | ﹤0.01% | 1750 |
|
|
2022
Q2 | $567K | Sell |
9,722
-2,313
| -19% | -$135K | ﹤0.01% | 1094 |
|
|
2022
Q1 | $919K | Buy |
12,035
+9,499
| +375% | +$725K | 0.01% | 882 |
|
|
2021
Q4 | $153K | Buy |
2,536
+99
| +4% | +$5.97K | ﹤0.01% | 1837 |
|
|
2021
Q3 | $136K | Sell |
2,437
-687
| -22% | -$38.3K | ﹤0.01% | 1833 |
|
|
2021
Q2 | $190K | Sell |
3,124
-4,801
| -61% | -$292K | ﹤0.01% | 1560 |
|
|
2021
Q1 | $555K | Buy |
7,925
+3,620
| +84% | +$254K | 0.01% | 924 |
|
|
2020
Q4 | $258K | Buy |
4,305
+367
| +9% | +$22K | ﹤0.01% | 1093 |
|
|
2020
Q3 | $236K | Buy |
3,938
+431
| +12% | +$25.8K | ﹤0.01% | 966 |
|
|
2020
Q2 | $186K | Buy |
3,507
+647
| +23% | +$34.3K | ﹤0.01% | 1065 |
|
|
2020
Q1 | $92K | Buy |
+2,860
| New | +$92K | ﹤0.01% | 1160 |
|
|
2018
Q2 | – | Sell |
-15
| Closed | – | – | 1584 |
|
|
2018
Q1 | $0 | Buy |
+15
| New | – | ﹤0.01% | 1365 |
|